ProMetic Life Sciences Inc. (TSE:PLI – Get Free Report)’s share price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$13.60 and traded as high as C$13.72. ProMetic Life Sciences shares last traded at C$13.60, with a volume of 921 shares.
ProMetic Life Sciences Stock Up 0.2 %
The firm has a 50-day moving average price of C$13.60. The stock has a market cap of C$317.06 million and a price-to-earnings ratio of -0.22. The company has a current ratio of 4.06, a quick ratio of 3.66 and a debt-to-equity ratio of 37.47.
ProMetic Life Sciences Company Profile
Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.
Read More
- Five stocks we like better than ProMetic Life Sciences
- What Are Growth Stocks and Investing in Them
- The Average 401k Balance by Age Explained
- Most active stocks: Dollar volume vs share volume
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 3 Fintech Stocks With Good 2021 Prospects
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
